meRfi®-GM
Heart Failure / Congestive Heart Failure (CHF)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Heart failure (HF), a complex clinical syndrome, is characterized by the heart's inability to pump sufficient blood to meet the body's needs.
The prevalence of heart failure in adults is 1 to 2% and in over 70-year-old >10%.
Heart failure is a difficult clinical syndrome with abnormal changes in the structure and function of the heart. Heart failure leads to ventricular systolic and or diastolic dysfunction
…
References (Sources)
- 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
- BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection
- Catheter Ablation for Atrial Fibrillation with Heart Failure
- CD36 as a target for metabolic modulation therapy in cardiac disease
- Clinical epidemiology of heart failure
- ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC
- STING-IRF3 contributes to lipopolysaccharide-induced cardiac dysfunction, inflammation, apoptosis and pyroptosis by activating NLRP3